ZONISAMIDE

ZONISAMIDE was reported 10719 times

ZONISAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPILEPSY WITH MYOCLONIC-ATONIC SEIZURES 11 0.3929
1 TUBEROUS SCLEROSIS COMPLEX 27 0.2571
2 OVARIAN GRANULOSA-THECA CELL TUMOUR 9 0.2571
3 TONSILLAR EXUDATE 10 0.2222
4 BRAIN LOBECTOMY 13 0.2203
5 HEREDITARY OPTIC ATROPHY 10 0.1429
6 POSTICTAL PSYCHOSIS 20 0.1282
7 CONGENITAL INTESTINAL MALFORMATION 13 0.1121
8 PERITONITIS SCLEROSING 9 0.1084
9 IDIOPATHIC GENERALISED EPILEPSY 9 0.1059
10 ATONIC SEIZURES 85 0.0990
11 MULTIPLE-DRUG RESISTANCE 291 0.0938
12 VAGAL NERVE STIMULATOR IMPLANTATION 28 0.0915
13 POSTICTAL PARALYSIS 21 0.0868
14 CONGENITAL APLASIA 23 0.0740
15 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 38 0.0710
16 SEIZURE CLUSTER 56 0.0676
17 NEONATAL PNEUMONIA 15 0.0638
18 CHANGE IN SEIZURE PRESENTATION 40 0.0618
19 VESTIBULAR MIGRAINE 14 0.0581
20 RETINOGRAM ABNORMAL 15 0.0560
21 ANTICOAGULATION DRUG LEVEL ABNORMAL 8 0.0537
22 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE 11 0.0500
23 EPILEPTIC ENCEPHALOPATHY 11 0.0493
24 HERPES OESOPHAGITIS 10 0.0467
25 FOCAL DYSCOGNITIVE SEIZURES 51 0.0448
26 INFANTILE SPASMS 32 0.0443
27 AUTOMATISM 9 0.0417
28 MYOCLONIC EPILEPSY 63 0.0415
29 NEONATAL HYPOTENSION 15 0.0408
30 DEJA VU 11 0.0400
31 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 14 0.0399
32 COMPLEX PARTIAL SEIZURES 43 0.0387
33 CONGENITAL INGUINAL HERNIA 8 0.0383
34 FOETAL MALFORMATION 40 0.0368
35 TONIC CONVULSION 50 0.0353
36 CYTOTOXIC OEDEMA 9 0.0340
37 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 15 0.0321
38 TONSILLAR INFLAMMATION 10 0.0311
39 CHOROIDAL EFFUSION 24 0.0299
40 PARTIAL SEIZURES 156 0.0298
41 ANTICONVULSANT DRUG LEVEL INCREASED 48 0.0297
42 STATUS EPILEPTICUS 321 0.0284
43 OCULOMUCOCUTANEOUS SYNDROME 12 0.0282
44 DROPPED HEAD SYNDROME 11 0.0278
45 HYPERAMMONAEMIC ENCEPHALOPATHY 48 0.0276
46 TEMPORAL LOBE EPILEPSY 12 0.0275
47 BRONCHIAL HYPERREACTIVITY 33 0.0274
48 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0270
49 CALCULUS URINARY 40 0.0260
50 CYTOGENETIC ABNORMALITY 28 0.0248
51 INTENTION TREMOR 14 0.0246
52 SPINA BIFIDA 50 0.0240
53 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77 0.0237
54 FANCONI SYNDROME 32 0.0226
55 VERBAL ABUSE 11 0.0224
56 PETIT MAL EPILEPSY 112 0.0219
57 DRUG WITHDRAWAL CONVULSIONS 39 0.0219
58 DROP ATTACKS 13 0.0219
59 LYMPHOCYTE STIMULATION TEST POSITIVE 17 0.0212
60 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0199
61 AURA 37 0.0198
62 INTELLECTUAL DISABILITY 29 0.0191
63 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 12 0.0185
64 GENERALISED TONIC-CLONIC SEIZURE 306 0.0185
65 ELECTROCARDIOGRAM PR PROLONGATION 14 0.0183
66 CEREBELLAR ATROPHY 16 0.0182
67 CLONIC CONVULSION 13 0.0178
68 ELECTROENCEPHALOGRAM ABNORMAL 56 0.0177
69 ANTICONVULSANT DRUG LEVEL DECREASED 25 0.0177
70 ATAXIA 206 0.0173
71 RENAL TUBULAR ACIDOSIS 34 0.0156
72 BEHAVIOUR DISORDER 84 0.0155
73 POSTICTAL STATE 16 0.0154
74 DYSMETRIA 9 0.0149
75 INFANTILE APNOEA 12 0.0147
76 BREAST DISORDER 30 0.0147
77 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 11 0.0146
78 SEIZURE 1689 0.0146
79 CLEFT PALATE 27 0.0140
80 RECALLED PRODUCT ADMINISTERED 133 0.0139
81 SIMPLE PARTIAL SEIZURES 11 0.0136
82 EPILEPSY 408 0.0133
83 VANISHING BILE DUCT SYNDROME 14 0.0126
84 UPPER RESPIRATORY TRACT INFLAMMATION 15 0.0125
85 CALCULUS URETERIC 9 0.0124
86 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 50 0.0120
87 INDIFFERENCE 9 0.0120
88 PSYCHOGENIC SEIZURE 11 0.0118
89 GRAND MAL CONVULSION 107 0.0116
90 SINUS ARRHYTHMIA 15 0.0115
91 CEREBELLAR ATAXIA 11 0.0115
92 CONVULSION 622 0.0109
93 STARING 26 0.0107
94 FOOD REFUSAL 9 0.0103
95 CROSS SENSITIVITY REACTION 10 0.0103
96 RESPIRATORY DISORDER NEONATAL 16 0.0099
97 HYPERAMMONAEMIA 49 0.0098
98 LANGUAGE DISORDER 21 0.0097
99 MYOCLONUS 114 0.0095
100 PLACENTAL DISORDER 9 0.0095
101 POLYDACTYLY 11 0.0095
102 DEATH NEONATAL 13 0.0093
103 HUMAN HERPESVIRUS 6 INFECTION 17 0.0090
104 NYSTAGMUS 46 0.0087
105 FOETAL ANTICONVULSANT SYNDROME 10 0.0084
106 SUICIDAL BEHAVIOUR 35 0.0084
107 HYPOTONIA NEONATAL 13 0.0083
108 PERSECUTORY DELUSION 20 0.0080
109 IMMUNOGLOBULINS DECREASED 11 0.0080
110 BRAIN OPERATION 18 0.0079
111 IMPULSE-CONTROL DISORDER 16 0.0078
112 TONIC CLONIC MOVEMENTS 10 0.0077
113 HYPOSPADIAS 16 0.0077
114 DYSMORPHISM 18 0.0076
115 LICHEN PLANUS 17 0.0073
116 GASTROSTOMY 11 0.0071
117 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 14 0.0071
118 MICROCEPHALY 9 0.0070
119 MULTIPLE CONGENITAL ABNORMALITIES 10 0.0069
120 INAPPROPRIATE AFFECT 11 0.0069
121 MUTISM 10 0.0069
122 PSYCHOMOTOR SKILLS IMPAIRED 18 0.0069
123 TOXIC EPIDERMAL NECROLYSIS 104 0.0068
124 TORTICOLLIS 14 0.0066
125 DAYDREAMING 10 0.0065
126 ENURESIS 26 0.0064
127 DEVELOPMENTAL DELAY 58 0.0064
128 AGGRESSION 320 0.0064
129 DROOLING 44 0.0064
130 AKINESIA 13 0.0063
131 STEVENS-JOHNSON SYNDROME 139 0.0062
132 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 158 0.0061
133 FLAT AFFECT 14 0.0060
134 TACHYARRHYTHMIA 15 0.0060
135 ENDOMETRIAL CANCER 13 0.0059
136 POSTURE ABNORMAL 19 0.0058
137 OSTEOMALACIA 9 0.0058
138 POLYDIPSIA 23 0.0058
139 BLOOD BICARBONATE DECREASED 11 0.0058
140 HYPOTONIA 58 0.0058
141 AMMONIA INCREASED 29 0.0057
142 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 15 0.0056
143 PNEUMONIA ASPIRATION 140 0.0056
144 ANGLE CLOSURE GLAUCOMA 14 0.0055
145 DRUG ERUPTION 95 0.0054
146 PSYCHOMOTOR RETARDATION 15 0.0053
147 VITAMIN D DEFICIENCY 52 0.0053
148 PSYCHOTIC SYMPTOM 11 0.0053
149 DRUG RESISTANCE 133 0.0052
150 LOGORRHOEA 18 0.0051
151 DEPRESSIVE SYMPTOM 18 0.0051
152 SEDATION 132 0.0050
153 HYPERNATRAEMIA 25 0.0050
154 FACIAL BONES FRACTURE 18 0.0050
155 METABOLIC ENCEPHALOPATHY 15 0.0050
156 SALIVARY HYPERSECRETION 50 0.0050
157 PSYCHOTIC DISORDER 146 0.0049
158 HOMICIDAL IDEATION 20 0.0049
159 SMALL FOR DATES BABY 24 0.0048
160 AFFECTIVE DISORDER 38 0.0048
161 MICROCYTIC ANAEMIA 10 0.0048
162 BODY TEMPERATURE FLUCTUATION 10 0.0048
163 IMPATIENCE 9 0.0048
164 COGNITIVE DISORDER 223 0.0048
165 GINGIVAL RECESSION 9 0.0047
166 EYE MOVEMENT DISORDER 32 0.0047
167 DRUG TITRATION ERROR 12 0.0046
168 ABNORMAL BEHAVIOUR 182 0.0046
169 STRABISMUS 13 0.0044
170 RENAL COLIC 10 0.0044
171 DYSPHEMIA 19 0.0043
172 HALLUCINATIONS, MIXED 18 0.0043
173 DIPLOPIA 111 0.0043
174 MENOPAUSE 11 0.0043
175 DYSAESTHESIA 13 0.0042
176 AORTIC VALVE INCOMPETENCE 18 0.0042
177 IRRITABILITY 253 0.0042
178 MYOPIA 10 0.0042
179 NEPHROLITHIASIS 191 0.0042
180 NEUROLEPTIC MALIGNANT SYNDROME 49 0.0041
181 SCREAMING 26 0.0041
182 MOTOR DYSFUNCTION 41 0.0040
183 ALTERED STATE OF CONSCIOUSNESS 87 0.0040
184 CEREBRAL ATROPHY 16 0.0040
185 DELUSION 62 0.0040
186 GESTATIONAL DIABETES 19 0.0040
187 FOETAL GROWTH RESTRICTION 24 0.0039
188 HOSTILITY 10 0.0039
189 ENCEPHALOPATHY 96 0.0039
190 BRADYKINESIA 23 0.0039
191 TALIPES 12 0.0039
192 PSYCHIATRIC SYMPTOM 28 0.0038
193 HALLUCINATION, VISUAL 80 0.0038
194 STRESS CARDIOMYOPATHY 22 0.0038
195 ON AND OFF PHENOMENON 21 0.0038
196 DYSKINESIA 153 0.0038
197 WRONG PATIENT RECEIVED PRODUCT 11 0.0038
198 STILLBIRTH 18 0.0037
199 SELF ESTEEM DECREASED 9 0.0037
200 PERSONALITY CHANGE 34 0.0037
201 CEREBELLAR SYNDROME 8 0.0036
202 HALLUCINATION, AUDITORY 58 0.0036
203 TRICUSPID VALVE INCOMPETENCE 29 0.0036
204 FOETAL EXPOSURE DURING PREGNANCY 295 0.0036
205 HYPERPARATHYROIDISM SECONDARY 9 0.0036
206 DRUG LEVEL INCREASED 59 0.0036
207 HYPOTHERMIA 36 0.0036
208 PARKINSON'S DISEASE 9 0.0035
209 DRUG LEVEL DECREASED 36 0.0035
210 SEDATION COMPLICATION 9 0.0035
211 HEPATOSPLENOMEGALY 9 0.0035
212 BIPOLAR DISORDER 38 0.0035
213 HEPATITIS TOXIC 9 0.0035
214 SOMNOLENCE 691 0.0034
215 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
216 PARANOIA 59 0.0034
217 PARKINSONISM 33 0.0034
218 FEELING DRUNK 25 0.0034
219 BRUXISM 18 0.0033
220 HYPERCAPNIA 10 0.0033
221 PSYCHOMOTOR HYPERACTIVITY 55 0.0033
222 MIGRAINE WITH AURA 9 0.0033
223 HYDROCEPHALUS 18 0.0033
224 CLUMSINESS 9 0.0033
225 STOMA SITE DISCHARGE 9 0.0033
226 SELF INJURIOUS BEHAVIOUR 10 0.0033
227 MUSCLE RIGIDITY 39 0.0033
228 DRUG SCREEN FALSE POSITIVE 9 0.0032
229 ACUTE PSYCHOSIS 8 0.0032
230 ATRIAL SEPTAL DEFECT 27 0.0032
231 IMPULSIVE BEHAVIOUR 12 0.0032
232 DYSARTHRIA 120 0.0032
233 APHASIA 96 0.0032
234 GINGIVAL DISORDER 12 0.0031
235 AUTISM SPECTRUM DISORDER 17 0.0031
236 RHINOVIRUS INFECTION 12 0.0031
237 HYPOVENTILATION 10 0.0031
238 BRADYPHRENIA 20 0.0031
239 DEAFNESS NEUROSENSORY 10 0.0030
240 DRUG INTERACTION 482 0.0030
241 HYPERSOMNIA 87 0.0030
242 NEPHROGENIC ANAEMIA 14 0.0030
243 LOW BIRTH WEIGHT BABY 24 0.0030
244 ANGER 102 0.0030
245 TYPE 1 DIABETES MELLITUS 18 0.0030
246 BRAIN NEOPLASM 27 0.0029
247 PRODUCT ADMINISTRATION INTERRUPTED 23 0.0029
248 FAECAL INCONTINENCE 14 0.0029
249 MOOD ALTERED 79 0.0029
250 ENCEPHALITIS 20 0.0029
251 ACIDOSIS 22 0.0029
252 COMMUNICATION DISORDER 11 0.0029
253 ABORTION INDUCED 27 0.0029
254 DIABETIC NEUROPATHY 14 0.0028
255 MOOD SWINGS 90 0.0028
256 PRODUCT PREPARATION ISSUE 18 0.0027
257 APATHY 40 0.0027
258 MIGRAINE 260 0.0027
259 GRANULOCYTOPENIA 15 0.0026
260 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
261 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
262 VENTRICULAR SEPTAL DEFECT 15 0.0026
263 CLAVICLE FRACTURE 10 0.0026
264 CERVICAL VERTEBRAL FRACTURE 9 0.0026
265 SCOLIOSIS 16 0.0026
266 MANIA 42 0.0026
267 AGITATION 187 0.0025
268 AGRANULOCYTOSIS 47 0.0025
269 THERAPEUTIC RESPONSE CHANGED 16 0.0025
270 THINKING ABNORMAL 47 0.0025
271 URINE OUTPUT DECREASED 22 0.0025
272 MAJOR DEPRESSION 18 0.0025
273 METABOLIC ACIDOSIS 78 0.0024
274 CEREBRAL DISORDER 18 0.0024
275 HEAD INJURY 77 0.0024
276 SPEECH DISORDER 127 0.0024
277 HALLUCINATION 181 0.0024
278 ANXIETY DISORDER 8 0.0024
279 MITRAL VALVE INCOMPETENCE 27 0.0024
280 SELF-INJURIOUS IDEATION 10 0.0024
281 ATELECTASIS 23 0.0024
282 PRESCRIBED OVERDOSE 46 0.0024
283 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
284 DRUG TOLERANCE 12 0.0024
285 FACE INJURY 9 0.0024
286 OBSESSIVE-COMPULSIVE DISORDER 19 0.0024
287 TREATMENT FAILURE 196 0.0024
288 ERYTHEMA MULTIFORME 22 0.0024
289 B-CELL LYMPHOMA 8 0.0024
290 VISUAL FIELD DEFECT 17 0.0024
291 MATERNAL DRUGS AFFECTING FOETUS 18 0.0023
292 FEMORAL NECK FRACTURE 12 0.0023
293 AMNESIA 152 0.0023
294 SKIN ABRASION 11 0.0023
295 HYPOCALCAEMIA 44 0.0023
296 APLASTIC ANAEMIA 12 0.0023
297 COORDINATION ABNORMAL 32 0.0023
298 BALANCE DISORDER 197 0.0023
299 PRODUCT SUBSTITUTION ISSUE 131 0.0023
300 BRONCHIOLITIS 8 0.0023
301 DISTURBANCE IN ATTENTION 122 0.0023
302 HYPERPHAGIA 9 0.0023
303 SUICIDAL IDEATION 206 0.0022
304 PRODUCT SUPPLY ISSUE 16 0.0022
305 HYPERTHERMIA 17 0.0022
306 DISSEMINATED INTRAVASCULAR COAGULATION 31 0.0022
307 MATERNAL EXPOSURE BEFORE PREGNANCY 15 0.0022
308 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
309 SOCIAL PROBLEM 9 0.0022
310 PREGNANCY 43 0.0021
311 INGUINAL HERNIA 13 0.0021
312 PRE-ECLAMPSIA 10 0.0021
313 ASPIRATION 23 0.0021
314 HYPERTONIA 12 0.0021
315 VISUAL DISTURBANCE 12 0.0021
316 PRE-EXISTING CONDITION IMPROVED 13 0.0021
317 PYELONEPHRITIS 18 0.0021
318 ABORTION SPONTANEOUS 83 0.0021
319 HYPOKINESIA 30 0.0021
320 APNOEA 16 0.0021
321 DEPRESSED LEVEL OF CONSCIOUSNESS 81 0.0020
322 HEPATIC FUNCTION ABNORMAL 76 0.0020
323 DRUG EXPOSURE DURING PREGNANCY 69 0.0020
324 ANAL INCONTINENCE 18 0.0020
325 FLUID INTAKE REDUCED 10 0.0020
326 INTENTIONAL SELF-INJURY 40 0.0020
327 RESTLESS LEGS SYNDROME 36 0.0020
328 BRAIN OEDEMA 25 0.0020
329 HYPOGAMMAGLOBULINAEMIA 13 0.0020
330 LETHARGY 113 0.0020
331 MUSCLE TWITCHING 45 0.0020
332 MENTAL IMPAIRMENT 47 0.0019
333 CONCUSSION 15 0.0019
334 UNRESPONSIVE TO STIMULI 50 0.0019
335 EXPOSURE DURING PREGNANCY 120 0.0019
336 FAILURE TO THRIVE 10 0.0019
337 DRUG TOXICITY 26 0.0019
338 DYSTONIA 37 0.0019
339 BLINDNESS TRANSIENT 14 0.0019
340 HYPERVENTILATION 11 0.0019
341 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 104 0.0019
342 PREMATURE BABY 57 0.0019
343 DEPRESSED MOOD 100 0.0019
344 HYPOKALAEMIA 86 0.0019
345 MATERNAL EXPOSURE DURING PREGNANCY 166 0.0019
346 CRYING 67 0.0018
347 PREMATURE DELIVERY 29 0.0018
348 MULTIPLE DRUG OVERDOSE 9 0.0018
349 LACERATION 17 0.0018
350 MEMORY IMPAIRMENT 248 0.0018
351 MENTAL STATUS CHANGES 50 0.0018
352 DERMATITIS EXFOLIATIVE 9 0.0018
353 MUSCLE SPASTICITY 22 0.0018
354 TOXIC ENCEPHALOPATHY 9 0.0018
355 BRADYCARDIA 94 0.0018
356 TREMOR 294 0.0018
357 FRACTURE 33 0.0017
358 RESPIRATORY DISTRESS 48 0.0017
359 HYDRONEPHROSIS 13 0.0017
360 THERAPY PARTIAL RESPONDER 27 0.0017
361 SLEEP APNOEA SYNDROME 33 0.0017
362 PEMPHIGOID 13 0.0017
363 CATATONIA 9 0.0017
364 DECREASED INTEREST 10 0.0017
365 BRAIN INJURY 17 0.0017
366 THERMAL BURN 12 0.0017
367 DISORIENTATION 67 0.0017
368 EMOTIONAL DISORDER 52 0.0017
369 CONGENITAL ANOMALY 13 0.0017
370 POISONING 21 0.0017
371 RESTLESSNESS 61 0.0017
372 SEROTONIN SYNDROME 32 0.0017
373 INFUSION SITE ERYTHEMA 14 0.0017
374 BRAIN FOG 26 0.0017
375 TIC 9 0.0016
376 DEPRESSION 373 0.0016
377 RESPIRATORY DEPRESSION 20 0.0016
378 LIGAMENT SPRAIN 16 0.0016
379 INTRACRANIAL PRESSURE INCREASED 9 0.0016
380 PRESCRIBED UNDERDOSE 32 0.0016
381 COMA 76 0.0016
382 PANIC ATTACK 58 0.0016
383 URINARY INCONTINENCE 47 0.0016
384 IMPAIRED DRIVING ABILITY 18 0.0016
385 GENERALISED ERYTHEMA 9 0.0016
386 FALL 522 0.0016
387 LOSS OF CONSCIOUSNESS 200 0.0016
388 INITIAL INSOMNIA 16 0.0016
389 NO THERAPEUTIC RESPONSE 19 0.0016
390 OCCUPATIONAL EXPOSURE TO PRODUCT 10 0.0016
391 SOCIAL AVOIDANT BEHAVIOUR 9 0.0016
392 SINUS BRADYCARDIA 15 0.0016
393 INCOHERENT 10 0.0015
394 HYPOALBUMINAEMIA 12 0.0015
395 PHARMACEUTICAL PRODUCT COMPLAINT 40 0.0015
396 CONDITION AGGRAVATED 467 0.0015
397 RESPIRATORY TRACT INFECTION 40 0.0015
398 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
399 BODY TEMPERATURE DECREASED 15 0.0015
400 SOMNAMBULISM 10 0.0015
401 DRUG INTOLERANCE 147 0.0015
402 DRUG SCREEN POSITIVE 12 0.0015
403 FAECES SOFT 11 0.0015
404 GAIT DISTURBANCE 289 0.0015
405 REBOUND EFFECT 17 0.0015
406 EAR INFECTION 40 0.0015
407 BLOOD POTASSIUM DECREASED 45 0.0015
408 MENTAL DISORDER 65 0.0015
409 COMPRESSION FRACTURE 8 0.0015
410 SPINAL OSTEOARTHRITIS 13 0.0015
411 ANOREXIA 19 0.0015
412 SUBARACHNOID HAEMORRHAGE 15 0.0015
413 DECREASED APPETITE 342 0.0015
414 VIRAL INFECTION 49 0.0015
415 THERAPY NON-RESPONDER 66 0.0015
416 AKATHISIA 20 0.0015
417 CAESAREAN SECTION 17 0.0015
418 ADVERSE DRUG REACTION 131 0.0015
419 RIB FRACTURE 30 0.0015
420 SPINAL COMPRESSION FRACTURE 12 0.0014
421 TOOTH FRACTURE 16 0.0014
422 SUICIDE ATTEMPT 88 0.0014
423 ORTHOSTATIC HYPOTENSION 25 0.0014
424 INFUSION SITE SWELLING 9 0.0014
425 INCONTINENCE 15 0.0014
426 INTENTIONAL OVERDOSE 91 0.0014
427 PNEUMONIA BACTERIAL 13 0.0014
428 QUALITY OF LIFE DECREASED 19 0.0014
429 DELIRIUM 49 0.0014
430 INSOMNIA 376 0.0014
431 MYDRIASIS 18 0.0014
432 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
433 PARALYSIS 20 0.0014
434 TONGUE DISORDER 10 0.0014
435 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 98 0.0014
436 SLEEP DISORDER 97 0.0014
437 INSURANCE ISSUE 21 0.0014
438 FOOT FRACTURE 26 0.0014
439 DRUG-INDUCED LIVER INJURY 43 0.0014
440 EOSINOPHILIA 24 0.0014
441 ILEUS 17 0.0014
442 HYPONATRAEMIA 77 0.0014
443 LIMB INJURY 37 0.0014
444 VERTIGO 83 0.0014
445 INCREASED APPETITE 26 0.0014
446 HEMIPARESIS 23 0.0014
447 WEIGHT DECREASED 379 0.0014
448 ADVERSE REACTION 18 0.0014
449 DECUBITUS ULCER 11 0.0013
450 VISION BLURRED 185 0.0013
451 MALNUTRITION 15 0.0013
452 MOVEMENT DISORDER 43 0.0013
453 ABASIA 33 0.0013
454 ELECTROCARDIOGRAM QT PROLONGED 48 0.0013
455 HYPOPHAGIA 34 0.0013
456 PHOTOPHOBIA 25 0.0013
457 THERAPY CHANGE 13 0.0013
458 PRODUCT USE IN UNAPPROVED INDICATION 327 0.0013
459 URINARY RETENTION 44 0.0013
460 CONFUSIONAL STATE 213 0.0013
461 MICTURITION URGENCY 15 0.0013
462 JOINT INJURY 28 0.0013
463 RESPIRATION ABNORMAL 9 0.0013
464 DRUG INEFFECTIVE 1716 0.0013
465 FEAR 35 0.0013
466 ANKLE FRACTURE 20 0.0013
467 TOXIC SKIN ERUPTION 13 0.0013
468 WITHDRAWAL SYNDROME 54 0.0013
469 EAR PAIN 25 0.0013
470 CARPAL TUNNEL SYNDROME 18 0.0013
471 SCAR 22 0.0013
472 SOPOR 17 0.0013
473 SLUGGISHNESS 13 0.0013
474 CARDIAC MURMUR 11 0.0013
475 BLEPHAROSPASM 8 0.0013
476 HAND FRACTURE 9 0.0013
477 NERVOUSNESS 66 0.0013
478 FOOT DEFORMITY 14 0.0013
479 BLOOD CREATINE PHOSPHOKINASE INCREASED 36 0.0012
480 IMPAIRED GASTRIC EMPTYING 17 0.0012
481 AFFECT LABILITY 12 0.0012
482 RHABDOMYOLYSIS 52 0.0012
483 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
484 INFUSION SITE PAIN 16 0.0012
485 PRODUCT PRESCRIBING ISSUE 27 0.0012
486 RASH GENERALISED 32 0.0012
487 SCRATCH 13 0.0012
488 ASPARTATE AMINOTRANSFERASE INCREASED 65 0.0012
489 CARDIO-RESPIRATORY ARREST 51 0.0012
490 TYPE 2 DIABETES MELLITUS 41 0.0012
491 OROPHARYNGEAL DISCOMFORT 11 0.0012
492 HYPOPHOSPHATAEMIA 9 0.0012
493 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
494 PHARYNGITIS STREPTOCOCCAL 13 0.0012
495 SEASONAL ALLERGY 17 0.0012
496 BACK INJURY 13 0.0012
497 LIVER DISORDER 53 0.0012
498 PAROSMIA 9 0.0012
499 FEEDING DISORDER 24 0.0012
500 FEELING ABNORMAL 283 0.0012
501 DISSOCIATION 9 0.0012
502 ABNORMAL LOSS OF WEIGHT 8 0.0012
503 DIZZINESS 584 0.0012
504 WEIGHT INCREASED 262 0.0012
505 RESPIRATORY DISORDER 35 0.0012
506 MUSCULOSKELETAL CHEST PAIN 18 0.0012
507 TEMPERATURE INTOLERANCE 12 0.0012
508 BLOOD CALCIUM DECREASED 13 0.0012
509 PELVIC FRACTURE 9 0.0012
510 PULMONARY HYPERTENSION 24 0.0012
511 ROAD TRAFFIC ACCIDENT 48 0.0011
512 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
513 POST PROCEDURAL COMPLICATION 22 0.0011
514 ACUTE RESPIRATORY FAILURE 22 0.0011
515 DYSPHAGIA 108 0.0011
516 SMALL INTESTINAL OBSTRUCTION 14 0.0011
517 ANXIETY 323 0.0011
518 SUDDEN DEATH 12 0.0011
519 BLOOD TRIGLYCERIDES INCREASED 20 0.0011
520 PHARYNGITIS 14 0.0011
521 NIGHTMARE 39 0.0011
522 RESPIRATORY ARREST 31 0.0011
523 OSTEOPENIA 17 0.0011
524 GASTROINTESTINAL INFECTION 10 0.0011
525 DERMATITIS ALLERGIC 14 0.0011
526 HEAVY MENSTRUAL BLEEDING 10 0.0011
527 CONTUSION 107 0.0011
528 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
529 INABILITY TO AFFORD MEDICATION 11 0.0011
530 OFF LABEL USE 962 0.0011
531 OESOPHAGITIS 12 0.0011
532 RESPIRATORY FAILURE 80 0.0011
533 HICCUPS 9 0.0011
534 SHOCK 25 0.0011
535 DENTAL CARIES 12 0.0011
536 CARDIOMYOPATHY 16 0.0011
537 CYANOSIS 17 0.0011
538 NERVE INJURY 12 0.0011
539 PRODUCT USE COMPLAINT 17 0.0011
540 POLLAKIURIA 45 0.0011
541 TREATMENT NONCOMPLIANCE 59 0.0011
542 LYMPHADENOPATHY 38 0.0011
543 BLOOD LACTATE DEHYDROGENASE INCREASED 17 0.0011
544 MIDDLE INSOMNIA 20 0.0011
545 DEVICE OCCLUSION 15 0.0011
546 BEDRIDDEN 14 0.0011
547 PANCREATITIS 56 0.0011
548 SENSORY DISTURBANCE 17 0.0011
549 SINUS TACHYCARDIA 15 0.0011
550 TOXICITY TO VARIOUS AGENTS 178 0.0011
551 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
552 SUBDURAL HAEMATOMA 15 0.0010
553 ANURIA 9 0.0010
554 PRODUCT DOSE OMISSION ISSUE 307 0.0010
555 JOINT DISLOCATION 11 0.0010
556 MUSCLE STRAIN 9 0.0010
557 HYSTERECTOMY 9 0.0010
558 MUSCULAR WEAKNESS 118 0.0010
559 RASH MACULO-PAPULAR 23 0.0010
560 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
561 EATING DISORDER 22 0.0010
562 DYSSTASIA 30 0.0010
563 POOR QUALITY SLEEP 22 0.0010
564 URINARY TRACT INFECTION 174 0.0010
565 DECREASED ACTIVITY 11 0.0010
566 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
567 LYMPHOCYTE COUNT DECREASED 18 0.0010
568 MENSTRUATION DELAYED 11 0.0010
569 SKIN LACERATION 11 0.0010
570 PRODUCT AVAILABILITY ISSUE 23 0.0010
571 OBESITY 16 0.0010
572 HYPERLIPIDAEMIA 12 0.0010
573 UPPER LIMB FRACTURE 20 0.0010
574 THERAPEUTIC RESPONSE UNEXPECTED 45 0.0010
575 DRUG EFFECT DECREASED 54 0.0010
576 NECK PAIN 56 0.0010
577 DEMENTIA 28 0.0010
578 GASTROENTERITIS VIRAL 18 0.0010
579 UPPER RESPIRATORY TRACT INFECTION 46 0.0010
580 PYREXIA 344 0.0010
581 PRODUCT PHYSICAL ISSUE 20 0.0010
582 OPTIC NEURITIS 9 0.0010
583 CHOLESTASIS 19 0.0010
584 SEPTIC SHOCK 43 0.0010
585 MUSCLE TIGHTNESS 16 0.0010
586 OVERDOSE 213 0.0010
587 INCREASED TENDENCY TO BRUISE 9 0.0010
588 ALANINE AMINOTRANSFERASE INCREASED 60 0.0010
589 EUPHORIC MOOD 10 0.0010
590 PARAESTHESIA ORAL 14 0.0010
591 ACUTE CORONARY SYNDROME 8 0.0010
592 VOMITING 454 0.0010
593 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
594 BLOOD PRESSURE ABNORMAL 19 0.0010
595 GASTRITIS 25 0.0009
596 PNEUMONIA 307 0.0009
597 FIBROMYALGIA 23 0.0009
598 PRODUCT USE ISSUE 177 0.0009
599 FATIGUE 732 0.0009
600 SPLENOMEGALY 11 0.0009
601 ALOPECIA 184 0.0009
602 BLOOD IRON DECREASED 11 0.0009
603 HAEMORRHOIDS 18 0.0009
604 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 44 0.0009
605 HEPATOMEGALY 9 0.0009
606 CHOLELITHIASIS 30 0.0009
607 DEHYDRATION 122 0.0009
608 HOSPICE CARE 9 0.0009
609 PHOTOSENSITIVITY REACTION 15 0.0009
610 HEADACHE 569 0.0009
611 FEMUR FRACTURE 28 0.0009
612 HEAD DISCOMFORT 16 0.0009
613 LEUKOPENIA 45 0.0009
614 HEPATITIS 23 0.0009
615 TINNITUS 41 0.0009
616 GENERALISED OEDEMA 11 0.0009
617 CARDIAC ARREST 73 0.0009
618 LEUKOCYTOSIS 16 0.0009
619 TOOTH ABSCESS 9 0.0009
620 CONSTIPATION 192 0.0009
621 SECRETION DISCHARGE 11 0.0009
622 PERIPHERAL COLDNESS 12 0.0009
623 HYPOAESTHESIA 130 0.0009
624 ORAL DISCOMFORT 12 0.0009
625 DISEASE RECURRENCE 41 0.0009
626 PARAESTHESIA 135 0.0009
627 DIARRHOEA HAEMORRHAGIC 8 0.0009
628 AMENORRHOEA 15 0.0009
629 SURGERY 50 0.0009
630 BRONCHITIS 63 0.0009
631 SPINAL FRACTURE 17 0.0008
632 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
633 DRUG ADMINISTRATION ERROR 26 0.0008
634 GENERAL PHYSICAL HEALTH DETERIORATION 98 0.0008
635 HYPOTHYROIDISM 27 0.0008
636 GASTROOESOPHAGEAL REFLUX DISEASE 68 0.0008
637 RETCHING 18 0.0008
638 THYROID DISORDER 13 0.0008
639 IMPAIRED WORK ABILITY 18 0.0008
640 HEART RATE IRREGULAR 19 0.0008
641 THIRST 15 0.0008
642 IMPAIRED QUALITY OF LIFE 12 0.0008
643 WRIST FRACTURE 10 0.0008
644 HOSPITALISATION 127 0.0008
645 RENAL FAILURE ACUTE 35 0.0008
646 THERAPEUTIC RESPONSE DECREASED 50 0.0008
647 MALIGNANT MELANOMA 11 0.0008
648 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
649 DRUG DOSE OMISSION 134 0.0008
650 UNEVALUABLE EVENT 61 0.0008
651 BLADDER DISORDER 8 0.0008
652 GINGIVAL BLEEDING 11 0.0008
653 RASH 350 0.0008
654 CHRONIC KIDNEY DISEASE 61 0.0008
655 HAEMORRHAGE INTRACRANIAL 12 0.0008
656 MULTIPLE SCLEROSIS RELAPSE 55 0.0008
657 OSTEOPOROSIS 33 0.0008
658 ABNORMAL DREAMS 22 0.0008
659 HEPATIC FAILURE 24 0.0008
660 MULTIPLE SCLEROSIS 38 0.0008
661 BLOOD CHOLESTEROL INCREASED 37 0.0008
662 PRODUCT ADMINISTRATION ERROR 16 0.0008
663 VISUAL IMPAIRMENT 98 0.0008
664 HYPERSENSITIVITY 146 0.0008
665 VISUAL ACUITY REDUCED 26 0.0008
666 BLOOD PRESSURE DECREASED 52 0.0008
667 UNDERDOSE 57 0.0008
668 LOWER LIMB FRACTURE 15 0.0008
669 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
670 ELECTROLYTE IMBALANCE 9 0.0008
671 TOOTHACHE 14 0.0008
672 HAEMATOMA 20 0.0008
673 BONE DISORDER 14 0.0008
674 COMPLETED SUICIDE 64 0.0008
675 BLINDNESS 31 0.0008
676 ORAL PAIN 17 0.0008
677 PNEUMOTHORAX 12 0.0008
678 GASTROENTERITIS 11 0.0008
679 MULTI-ORGAN FAILURE 13 0.0008
680 PANCYTOPENIA 42 0.0008
681 PALPITATIONS 88 0.0008
682 BLOOD PRESSURE FLUCTUATION 18 0.0007
683 EYE PAIN 42 0.0007
684 DRUG EFFECT INCOMPLETE 27 0.0007
685 MUSCLE SPASMS 136 0.0007
686 INJURY 52 0.0007
687 PERICARDIAL EFFUSION 17 0.0007
688 BODY TEMPERATURE INCREASED 15 0.0007
689 PRODUCT DISPENSING ERROR 16 0.0007
690 CHEST PAIN 136 0.0007
691 NAUSEA 581 0.0007
692 HYPOAESTHESIA ORAL 11 0.0007
693 HYPOTENSION 146 0.0007
694 CYST 9 0.0007
695 GAIT INABILITY 24 0.0007
696 THROMBOCYTOPENIA 80 0.0007
697 ACUTE KIDNEY INJURY 109 0.0007
698 HEART RATE DECREASED 25 0.0007
699 MUSCLE ATROPHY 9 0.0007
700 PRODUCT DOSE OMISSION 46 0.0007
701 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
702 ABDOMINAL DISCOMFORT 118 0.0007
703 IRRITABLE BOWEL SYNDROME 15 0.0007
704 RED BLOOD CELL COUNT DECREASED 20 0.0007
705 GASTRIC DISORDER 24 0.0007
706 PALLOR 19 0.0007
707 HEPATIC STEATOSIS 13 0.0007
708 ARRHYTHMIA 33 0.0007
709 ASTHENIA 262 0.0007
710 CEREBRAL INFARCTION 17 0.0007
711 CELLULITIS 35 0.0007
712 NEUROPATHY PERIPHERAL 66 0.0007
713 PRURITUS GENERALISED 15 0.0007
714 CYSTITIS 22 0.0007
715 FUNGAL INFECTION 23 0.0007
716 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
717 HEART RATE INCREASED 68 0.0007
718 IMMUNE SYSTEM DISORDER 9 0.0007
719 PULMONARY CONGESTION 9 0.0007
720 INTERSTITIAL LUNG DISEASE 33 0.0007
721 DYSURIA 25 0.0007
722 HYPERHIDROSIS 87 0.0007
723 GLAUCOMA 13 0.0007
724 TRANSAMINASES INCREASED 15 0.0007
725 NERVOUS SYSTEM DISORDER 21 0.0007
726 PRODUCT PRESCRIBING ERROR 16 0.0007
727 CHOLECYSTITIS 8 0.0007
728 IMMUNODEFICIENCY 10 0.0007
729 ACCIDENT 8 0.0007
730 EYE DISORDER 22 0.0007
731 DIARRHOEA 430 0.0007
732 ABDOMINAL PAIN UPPER 137 0.0007
733 CHROMATURIA 15 0.0007
734 INTESTINAL OBSTRUCTION 25 0.0007
735 OROPHARYNGEAL PAIN 61 0.0007
736 PRESYNCOPE 16 0.0007
737 HAEMATOCRIT DECREASED 13 0.0007
738 DRUG DISPENSING ERROR 10 0.0007
739 LIMB DISCOMFORT 20 0.0006
740 CEREBRAL HAEMORRHAGE 23 0.0006
741 HAEMATURIA 22 0.0006
742 EPISTAXIS 48 0.0006
743 TACHYCARDIA 57 0.0006
744 AGEUSIA 16 0.0006
745 ILLNESS 66 0.0006
746 RENAL INJURY 19 0.0006
747 BLOOD SODIUM DECREASED 12 0.0006
748 WHITE BLOOD CELL COUNT DECREASED 69 0.0006
749 HEPATOCELLULAR INJURY 9 0.0006
750 ACCIDENTAL OVERDOSE 23 0.0006
751 BURNING SENSATION 44 0.0006
752 ABSCESS 10 0.0006
753 MOBILITY DECREASED 45 0.0006
754 DISEASE PROGRESSION 74 0.0006
755 NASOPHARYNGITIS 115 0.0006
756 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
757 DYSPEPSIA 61 0.0006
758 SYNCOPE 62 0.0006
759 SEPSIS 69 0.0006
760 DIABETES MELLITUS 47 0.0006
761 BACK DISORDER 10 0.0006
762 BACK PAIN 142 0.0006
763 RASH PRURITIC 33 0.0006
764 INFLUENZA LIKE ILLNESS 50 0.0006
765 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
766 PULMONARY MASS 9 0.0006
767 COLON CANCER 9 0.0006
768 PULMONARY OEDEMA 27 0.0006
769 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
770 RENAL IMPAIRMENT 50 0.0006
771 FREQUENT BOWEL MOVEMENTS 16 0.0006
772 PULMONARY EMBOLISM 56 0.0006
773 NEUTROPHIL COUNT DECREASED 24 0.0006
774 THERAPY INTERRUPTED 42 0.0006
775 OXYGEN SATURATION DECREASED 33 0.0006
776 LACTIC ACIDOSIS 19 0.0006
777 DIABETIC KETOACIDOSIS 14 0.0006
778 TENDONITIS 9 0.0006
779 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
780 MUSCULOSKELETAL DISORDER 11 0.0006
781 HYPERGLYCAEMIA 21 0.0006
782 STAPHYLOCOCCAL INFECTION 19 0.0006
783 LUNG DISORDER 28 0.0006
784 HYPERKALAEMIA 20 0.0006
785 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
786 RENAL FAILURE 75 0.0006
787 ADVERSE EVENT 52 0.0006
788 SKIN FISSURES 11 0.0006
789 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 114 0.0006
790 KIDNEY INFECTION 11 0.0006
791 INFECTION 81 0.0006
792 MALAISE 245 0.0006
793 SINUSITIS 57 0.0006
794 DEEP VEIN THROMBOSIS 36 0.0006
795 PLATELET COUNT DECREASED 59 0.0006
796 SWELLING FACE 36 0.0006
797 PRODUCT QUALITY ISSUE 75 0.0006
798 FLATULENCE 31 0.0005
799 ILL-DEFINED DISORDER 33 0.0005
800 ANAPHYLACTIC REACTION 30 0.0005
801 ACNE 41 0.0005
802 ASTHMA 61 0.0005
803 SKIN DISORDER 18 0.0005
804 DYSGEUSIA 40 0.0005
805 INFLUENZA 60 0.0005
806 HAEMOPTYSIS 15 0.0005
807 BLOOD UREA INCREASED 9 0.0005
808 PAIN IN EXTREMITY 158 0.0005
809 NEURALGIA 13 0.0005
810 BLISTER 30 0.0005
811 PANCREATITIS ACUTE 12 0.0005
812 FACE OEDEMA 9 0.0005
813 CANDIDA INFECTION 9 0.0005
814 TOOTH LOSS 11 0.0005
815 HIP FRACTURE 17 0.0005
816 NIGHT SWEATS 17 0.0005
817 MUSCULOSKELETAL DISCOMFORT 9 0.0005
818 SKIN DISCOLOURATION 24 0.0005
819 LIVER FUNCTION TEST ABNORMAL 15 0.0005
820 HYPOGLYCAEMIA 25 0.0005
821 GASTROINTESTINAL DISORDER 46 0.0005
822 HEPATIC ENZYME INCREASED 35 0.0005
823 URTICARIA 86 0.0005
824 LIVER FUNCTION TEST INCREASED 11 0.0005
825 STOMATITIS 31 0.0005
826 PAIN 313 0.0005
827 MENORRHAGIA 10 0.0005
828 DISCOMFORT 31 0.0005
829 ABDOMINAL PAIN 118 0.0005
830 MELAENA 11 0.0005
831 HAEMORRHAGE 52 0.0005
832 LOCALISED INFECTION 12 0.0005
833 PELVIC PAIN 9 0.0005
834 ANHEDONIA 13 0.0005
835 END STAGE RENAL DISEASE 9 0.0005
836 TASTE DISORDER 10 0.0005
837 BLOOD POTASSIUM INCREASED 8 0.0005
838 DRUG WITHDRAWAL SYNDROME 43 0.0005
839 FEELING HOT 30 0.0005
840 ABDOMINAL DISTENSION 51 0.0005
841 HERPES ZOSTER 28 0.0005
842 COVID-19 85 0.0005
843 INFLAMMATION 25 0.0005
844 JAUNDICE 13 0.0005
845 BACTERIAL INFECTION 9 0.0005
846 DRY MOUTH 39 0.0005
847 DYSPHONIA 28 0.0005
848 ABDOMINAL PAIN LOWER 12 0.0005
849 BLOOD URINE PRESENT 9 0.0005
850 RENAL DISORDER 22 0.0005
851 HYPERTENSION 100 0.0005
852 SWELLING 44 0.0005
853 INTENTIONAL PRODUCT MISUSE 41 0.0005
854 MUSCULOSKELETAL STIFFNESS 41 0.0005
855 CHOKING 9 0.0005
856 OEDEMA 25 0.0005
857 RASH ERYTHEMATOUS 22 0.0005
858 PAIN IN JAW 13 0.0005
859 PRURITUS 176 0.0005
860 RASH MACULAR 16 0.0005
861 INTENTIONAL DOSE OMISSION 13 0.0005
862 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
863 DISABILITY 9 0.0005
864 SINUS DISORDER 9 0.0005
865 HYPOXIA 16 0.0005
866 MYALGIA 77 0.0005
867 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
868 MEDICATION ERROR 25 0.0004
869 CEREBROVASCULAR ACCIDENT 76 0.0004
870 SWOLLEN TONGUE 14 0.0004
871 LIVER INJURY 11 0.0004
872 THERAPY CESSATION 23 0.0004
873 PERIPHERAL SWELLING 69 0.0004
874 ARTHRITIS 35 0.0004
875 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
876 PLEURAL EFFUSION 27 0.0004
877 OEDEMA PERIPHERAL 54 0.0004
878 C-REACTIVE PROTEIN INCREASED 16 0.0004
879 ECZEMA 23 0.0004
880 HAEMATEMESIS 11 0.0004
881 FLUID RETENTION 22 0.0004
882 FEELING COLD 12 0.0004
883 ERECTILE DYSFUNCTION 11 0.0004
884 KNEE ARTHROPLASTY 9 0.0004
885 MOUTH ULCERATION 9 0.0004
886 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
887 FLUSHING 43 0.0004
888 THROMBOSIS 34 0.0004
889 OCULAR HYPERAEMIA 20 0.0004
890 CHEST DISCOMFORT 43 0.0004
891 DRUG PRESCRIBING ERROR 8 0.0004
892 FAECES DISCOLOURED 9 0.0004
893 ARTHROPATHY 23 0.0004
894 NEUTROPENIA 56 0.0004
895 INCORRECT DOSE ADMINISTERED 94 0.0004
896 MENSTRUATION IRREGULAR 11 0.0004
897 CHILLS 48 0.0004
898 DRUG ABUSE 34 0.0004
899 SKIN LESION 11 0.0004
900 DRY EYE 20 0.0004
901 ANAEMIA 76 0.0004
902 BLOOD CREATININE INCREASED 26 0.0004
903 BLOOD GLUCOSE DECREASED 19 0.0004
904 BONE PAIN 23 0.0004
905 BLOOD PRESSURE INCREASED 60 0.0004
906 NASAL CONGESTION 23 0.0004
907 LIP SWELLING 13 0.0004
908 TARDIVE DYSKINESIA 11 0.0004
909 ERYTHEMA 80 0.0004
910 CATARACT 23 0.0004
911 DYSPNOEA 217 0.0004
912 DEAFNESS 10 0.0004
913 ATRIAL FIBRILLATION 37 0.0004
914 HAEMOGLOBIN DECREASED 39 0.0004
915 ARTHRALGIA 157 0.0004
916 CARDIAC DISORDER 35 0.0004
917 COUGH 104 0.0004
918 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
919 EXTRAPYRAMIDAL DISORDER 9 0.0004
920 PROCEDURAL PAIN 10 0.0004
921 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
922 INJECTION SITE BRUISING 28 0.0004
923 RECTAL HAEMORRHAGE 15 0.0003
924 HAEMATOCHEZIA 19 0.0003
925 APPLICATION SITE ERYTHEMA 9 0.0003
926 JOINT STIFFNESS 9 0.0003
927 ASCITES 10 0.0003
928 NO ADVERSE EVENT 61 0.0003
929 PRODUCTIVE COUGH 16 0.0003
930 BLOOD BILIRUBIN INCREASED 9 0.0003
931 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60 0.0003
932 THROAT TIGHTNESS 9 0.0003
933 HOT FLUSH 25 0.0003
934 LACRIMATION INCREASED 10 0.0003
935 EXPIRED PRODUCT ADMINISTERED 11 0.0003
936 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
937 RHINORRHOEA 21 0.0003
938 MUSCULOSKELETAL PAIN 17 0.0003
939 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
940 WOUND 9 0.0003
941 WHEEZING 19 0.0003
942 MYOCARDIAL INFARCTION 54 0.0003
943 OSTEOARTHRITIS 13 0.0003
944 INFUSION RELATED REACTION 20 0.0003
945 VAGINAL HAEMORRHAGE 13 0.0003
946 EYE PRURITUS 10 0.0003
947 INJECTION SITE MASS 11 0.0003
948 EYE SWELLING 11 0.0003
949 DRY SKIN 39 0.0003
950 THROAT IRRITATION 13 0.0003
951 NEOPLASM PROGRESSION 10 0.0003
952 CARDIAC FAILURE 23 0.0003
953 CARDIAC FAILURE CONGESTIVE 23 0.0003
954 EMOTIONAL DISTRESS 34 0.0003
955 PRODUCT ADHESION ISSUE 10 0.0003
956 DEVICE ISSUE 25 0.0003
957 DEVICE DISLOCATION 12 0.0003
958 IMPAIRED HEALING 9 0.0003
959 JOINT SWELLING 32 0.0003
960 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
961 INJECTION SITE HAEMORRHAGE 21 0.0003
962 SKIN IRRITATION 12 0.0003
963 SKIN EXFOLIATION 22 0.0003
964 EYE IRRITATION 15 0.0003
965 HYPOACUSIS 11 0.0003
966 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
967 BLOOD GLUCOSE INCREASED 47 0.0002
968 ANGIOEDEMA 11 0.0002
969 DEATH 207 0.0002
970 SKIN BURNING SENSATION 17 0.0002
971 INJECTION SITE REACTION 16 0.0002
972 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
973 COLITIS 8 0.0002
974 DERMATITIS ATOPIC 11 0.0002
975 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
976 INJECTION SITE PAIN 62 0.0002
977 COLITIS ULCERATIVE 9 0.0002
978 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
979 DEVICE BREAKAGE 8 0.0002
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
981 NEOPLASM MALIGNANT 12 0.0002
982 DRUG DEPENDENCE 28 0.0002
983 PRODUCT STORAGE ERROR 15 0.0002
984 INJECTION SITE SWELLING 13 0.0002
985 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
986 RHEUMATOID ARTHRITIS 19 0.0002
987 INJECTION SITE PRURITUS 11 0.0002
988 INJECTION SITE ERYTHEMA 20 0.0002
989 DEVICE MALFUNCTION 10 0.0001
990 PROSTATE CANCER 10 0.0001
991 PSORIASIS 16 0.0001
992 DRUG DOSE OMISSION BY DEVICE 8 0.0001
993 BREAST CANCER 9 0.0001